2023
Cognitive‐behavioral therapy for binge‐eating disorder for non‐responders to initial acute treatments: Randomized controlled trial
Grilo C, Lydecker J, Gueorguieva R. Cognitive‐behavioral therapy for binge‐eating disorder for non‐responders to initial acute treatments: Randomized controlled trial. International Journal Of Eating Disorders 2023, 56: 1544-1553. PMID: 37144325, PMCID: PMC10524840, DOI: 10.1002/eat.23975.Peer-Reviewed Original ResearchConceptsInitial acute treatmentBinge-eating disorderCognitive behavioral therapyAcute treatmentBinge-eating frequencyInitial interventionTherapist-led cognitive behavioural therapyInitial pharmacological treatmentTreat remission ratesEvidence-based treatmentsSingle-site trialAcute efficacyRemission rateAdult patientsInitial treatmentPharmacological treatmentPatientsPosttreatment assessmentBehavioral treatmentSufficient benefitTherapyDisordersInterventionTreatmentPharmacotherapy
2016
Combining Pharmacological and Psychological Treatments for Binge Eating Disorder: Current Status, Limitations, and Future Directions
Grilo CM, Reas DL, Mitchell JE. Combining Pharmacological and Psychological Treatments for Binge Eating Disorder: Current Status, Limitations, and Future Directions. Current Psychiatry Reports 2016, 18: 55. PMID: 27086316, DOI: 10.1007/s11920-016-0696-z.Peer-Reviewed Original ResearchConceptsCognitive behavioral therapyBinge Eating DisorderFuture treatment researchPsychological treatmentBehavioral therapyRecurrent bingeEating DisordersCompensatory behaviorsTreatment researchPharmacological treatmentHeightened levelsBehavioral weight loss interventionFuture researchWeight loss interventionLimited researchCurrent clinical practiceBingeCertain medicationsLoss interventionFuture directionsBWLClinical practiceWeight controlDisordersSuperior outcomes
2015
Pharmacological treatment of binge eating disorder: update review and synthesis
Reas DL, Grilo CM. Pharmacological treatment of binge eating disorder: update review and synthesis. Expert Opinion On Pharmacotherapy 2015, 16: 1463-1478. PMID: 26044518, PMCID: PMC4491373, DOI: 10.1517/14656566.2015.1053465.Peer-Reviewed Original ResearchConceptsCertain medicationsWeight lossDifferent medication classesOverview of pharmacotherapyMedical comorbiditiesMedication classesMinimal weight lossFirst medicationPharmacological treatmentRecurrent bingeLong-term effectsMedicationsSuperior outcomesMental disordersPharmacotherapyEvidence baseDisorder diagnosisStatistical ManualBingePhase IIIDisordersInclusion requirementsTrialsCombination approachRCTs